Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overcoming the “Valley of Death” in Medications Development for Alcohol Use Disorder
Lara A. Ray, Spencer Bujarski, Daniel Roche, et al.
Alcoholism Clinical and Experimental Research (2018) Vol. 42, Iss. 9, pp. 1612-1622
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Advances in the science and treatment of alcohol use disorder
Katie Witkiewitz, Raye Z. Litten, Lorenzo Leggio
Science Advances (2019) Vol. 5, Iss. 9
Open Access | Times Cited: 439
Overcoming the Valley of Death: A New Model for High Technology Startups
Saheed A. Gbadegeshin, Anas Al Natsheh, Kawtar Ghafel, et al.
Sustainable Futures (2022) Vol. 4, pp. 100077-100077
Open Access | Times Cited: 41
Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA
Amanda J. Abraham, Christina M. Andrews, Samantha J. Harris, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 1, pp. 55-69
Open Access | Times Cited: 66
Alcohol and Pain: A Translational Review of Preclinical and Clinical Findings to Inform Future Treatment Strategies
Scott Edwards, Leandro F. Vendruscolo, Nicholas W. Gilpin, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 44, Iss. 2, pp. 368-383
Open Access | Times Cited: 54
Translational opportunities in animal and human models to study alcohol use disorder
Steven J. Nieto, Erica N. Grodin, Claudia G. Aguirre, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 35
Alcohol-Induced Neuroinflammatory Response and Mitochondrial Dysfunction on Aging and Alzheimer’s Disease
Brandon Emanuel León, Shinwoo Kang, Gabriela Franca-Solomon, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 23
Social media as pharmacovigilance: The potential for patient reports to inform clinical research on glucagon-like peptide 1 (GLP-1) receptor agonists for substance use disorders
Michael P. Bremmer, Christian S. Hendershot
Journal of Studies on Alcohol and Drugs (2023)
Closed Access | Times Cited: 14
N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
Kevin M. Gray, Rachel L. Tomko, Nathaniel L. Baker, et al.
Neuropsychopharmacology (2025)
Open Access
The future of translational research on alcohol use disorder
Lara A. Ray, Erica N. Grodin, Lorenzo Leggio, et al.
Addiction Biology (2020) Vol. 26, Iss. 2
Open Access | Times Cited: 35
Applying the Addictions Neuroclinical Assessment to derive neurofunctional domains in individuals who use methamphetamine
Steven J. Nieto, Lara A. Ray
Behavioural Brain Research (2022) Vol. 427, pp. 113876-113876
Open Access | Times Cited: 17
The Interplay Between Subjective Response to Alcohol, Craving, and Alcohol Self‐Administration in the Human Laboratory
ReJoyce Green, Erica N. Grodin, Aaron C. Lim, et al.
Alcoholism Clinical and Experimental Research (2019) Vol. 43, Iss. 5, pp. 907-915
Open Access | Times Cited: 24
Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology
Lindsay R. Meredith, Elizabeth M. Burnette, Steven J. Nieto, et al.
Alcohol Clinical and Experimental Research (2023) Vol. 47, Iss. 9, pp. 1629-1645
Closed Access | Times Cited: 7
Repurposing drugs for treatment of alcohol use disorder
Henri‐Jean Aubin
International review of neurobiology (2024), pp. 153-185
Closed Access | Times Cited: 2
Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder
Lara A. Ray, Han Du, ReJoyce Green, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 519-527
Open Access | Times Cited: 18
Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why
Lara A. Ray, Erica N. Grodin
Annual Review of Clinical Psychology (2021) Vol. 17, Iss. 1, pp. 465-493
Closed Access | Times Cited: 16
N-acetylcysteine does not alter neurometabolite levels in non-treatment seeking adolescents who use alcohol heavily: A preliminary randomized clinical trial
Anna E. Kirkland, Brittney D. Browning, ReJoyce Green, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 8, pp. 1184-1193
Open Access | Times Cited: 6
Comparing alcohol cue-reactivity in treatment-seekers versus non-treatment-seekers with alcohol use disorder
Alexandra Venegas, Lara A. Ray
The American Journal of Drug and Alcohol Abuse (2019) Vol. 46, Iss. 1, pp. 131-138
Closed Access | Times Cited: 13
Characterizing alcohol cue reactive and non-reactive individuals with alcohol use disorder
Dylan Kirsch, Erica N. Grodin, Lara A. Ray
Addictive Behaviors (2024) Vol. 155, pp. 108028-108028
Closed Access | Times Cited: 1
Medication Development For Aud: A Systematic Review Of Clinical Trial Methodology
Stefano Di Donato, Lindsay R. Meredith, Steven J. Nieto, et al.
Alcohol (2024) Vol. 120, pp. 194-203
Closed Access | Times Cited: 1
SLC Neurotransmitter Transporters as Therapeutic Targets for Alcohol Use Disorder: A Narrative Review
Eliza R. McColl, Micheline Piquette‐Miller
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 10, pp. 1965-1976
Closed Access | Times Cited: 9
Are medication effects on subjective response to alcohol and cue-induced craving associated? A meta regression study
Lara A. Ray, Steven J. Nieto, Lindsay R. Meredith, et al.
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1921-1930
Open Access | Times Cited: 3
A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized clinical trial
Lara A. Ray, Wave‐Ananda Baskerville, Steven J. Nieto, et al.
Psychopharmacology (2023) Vol. 241, Iss. 3, pp. 543-553
Closed Access | Times Cited: 3
Outcome Assessment in Trials of Pharmacological Treatments for Alcohol Use Disorders: Fair and Strict Testing
Susanne Rösner, Michael Soyka
CNS Drugs (2019) Vol. 33, Iss. 7, pp. 649-657
Closed Access | Times Cited: 9
Alcohol Cue–Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self‐Administration
Aaron C. Lim, ReJoyce Green, Erica N. Grodin, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 44, Iss. 6, pp. 1224-1233
Open Access | Times Cited: 6
Using naltrexone to validate a human laboratory test system to screen new medications for alcoholism (TESMA)- a randomized clinical trial
Maik Spreer, Xina Grählert, Ina‐Maria Klut, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top